HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antimutagenicity of amifostine against the anticancer drug fotemustine in the Drosophila somatic mutation and recombination (SMART) test.

Abstract
Amifostine (WR-2721), a phosphorylated aminothiol pro-drug, is a selective cytoprotective agent in normal tissue against the toxicities associated with chemotherapy and irradiation. Fotemustine is a cancer chemotherapeutic agent that belongs to an extremely active class of alkylating compounds. Amifostine was tested for antimutagenicity against fotemustine in the somatic mutation and recombination test (SMART) in Drosophila melanogaster. Third-instar larvae that were trans-heterozygous for the two genetic markers mwh and flr were treated at different concentrations (2, 4, and 8 microg/ml for fotemustine and, 1, 2, and 4 microg/ml for amifostine) of the test compounds; for the antimutagenicity study, 8 microg/ml fotemustine plus 1 and 2 microg/ml amifostine were tested. Fotemustine showed mutagenic and recombinagenic effects in both genotypes in the wing-spot test. Amifostine significantly reduced the mutagenic and recombinagenic effects of fotemustine.
AuthorsN Aydemir, N Sevim, S Celikler, O Vatan, R Bilaloglu
JournalMutation research (Mutat Res) 2009 Sep-Oct Vol. 679 Issue 1-2 Pg. 1-5 ISSN: 0027-5107 [Print] Netherlands
PMID19712749 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antimutagenic Agents
  • Antineoplastic Agents
  • Nitrosourea Compounds
  • Organophosphorus Compounds
  • fotemustine
  • Amifostine
Topics
  • Amifostine (pharmacology)
  • Animals
  • Antimutagenic Agents (pharmacology)
  • Antineoplastic Agents (pharmacology)
  • Drosophila melanogaster (genetics)
  • Mutagenicity Tests
  • Nitrosourea Compounds (toxicity)
  • Organophosphorus Compounds (toxicity)
  • Recombination, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: